Advaxis Announces Filing for USDA Product License

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ACCV
2. IIB:IN
3. AZN
4. SMMT
5. GMAB
6. IVBIY
7. SPY
8. BMY
9. TSLA
10. JNJ

Go back to Advaxis Announces Filing for USDA Product License

Advaxis (ADXS) Reports Filing for ADXS-cHER2 Patent License (PETX)

July 2, 2014 8:36 AM EDT

Advaxis (Nasdaq: ADXS) announced that a product license from the United States Department of Agriculture (USDA) has been filed for ADXS-cHER2, its proprietary Her2/neu-directed cancer immunotherapy for the treatment of canine osteosarcoma and other HER2-overexpressing cancers. The filing was submitted by Aratana Therapeutics, Inc. (Nasdaq: PETX), which was granted exclusive worldwide rights by Advaxis to develop and commercialize ADXS-cHER2 (also known as AT-014 by Aratana) in animals. While the USDA has no specific obligation to... More